Skip to main content
. 2021 Dec;22(12):3741–3753. doi: 10.31557/APJCP.2021.22.12.3741

Table 7.

Univariate and Multivariate Cox Regression Analysis for RFS in HCC Patients with Tumor

Univariate Cox regression Multivariate Cox regression
Variables P-value HR 95% CI P-value HR 95% CI
Risk score(high/low) 0 3.45 2.05 5.82 0 3.86 2.48 6.01
Age (>60/≤60) 0.03 0.57 0.34 0.95
BMI 0.74
<25 Reference
≥25 0.85 0.47 1.54
Not reported 0.68 0.24 1.95
Race 0.32
Non-Asian Reference
Asian 1.21 0.6 2.43
Not reported 3.54 0.64 19.68
AFP 0.02
≤20ng/mL Reference Reference
˃20ng/ml 2.22 1.21 4.09 0.02 1.75 1.09 2.82
Not reported 1.92 0.8 4.64 0.24 1.35 0.82 2.21
Gender (Male/Female) 0.92 0.97 0.54 1.76
Hepatitis B or C 0.83
No Reference
Yes 1.2 0.61 2.35
Not reported 1.37 0.39 4.83
Alcohol 0.75
No Reference
Yes 0.91 0.5 1.65
Cirrhosis 0.88
No Reference
Yes 1.02 0.49 2.1
Not reported 1.21 0.56 2.6
Histologic grade 0.2
G1-2 Reference
G3-4 0.73 0.45 1.19
Not reported 2.51 0.57 11.01
New tumor event 0.96 3.53E+06 0 1.20E+273
Pathologic stage 0.01
Stage I+II Reference Reference
Stage III+IV 1.8 1.02 3.19 0.13 1.44 0.9 2.29
Not reported 0.43 0.15 1.23 0.06 0.51 0.25 1.03
Family cancer history 0.05
No Reference
Yes 0.84 0.46 1.52
Not reported 0.33 0.13 0.81
Residual tumor 0.89
R0 Reference
Non-R0 1.09 0.48 2.46
Not reported 1.66 0.18 15.11
Vascular invasion 0.01
Negative Reference Reference
Positive 1.96 1.09 3.49 0.37 1.23 0.78 1.94
Not reported 0.63 0.26 1.48 0.39 0.75 0.4 1.43

BMI, Body mass index; AFP, Alpha fetoprotein; HR, Hazard ratio; CI, Confidence interval.